Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10855371rdf:typepubmed:Citationlld:pubmed
pubmed-article:10855371lifeskim:mentionsumls-concept:C0242402lld:lifeskim
pubmed-article:10855371lifeskim:mentionsumls-concept:C0016296lld:lifeskim
pubmed-article:10855371lifeskim:mentionsumls-concept:C1328247lld:lifeskim
pubmed-article:10855371pubmed:dateCreated2000-7-19lld:pubmed
pubmed-article:10855371pubmed:abstractTextFifty-three heroin addicts, nineteen of them methadone treated, were asked about their use of flunitrazepam. Drug abuse began after a medical prescription in 50% of cases; flunitrazepam was taken per os, but also i.v. in 19% of cases. The mean daily dose was about 20 mg/day, often associated with other psychotropic drugs, alcohol, opiates or cocaine. Attention is focused on the amnesia and increased feeling of power (11% of cases), often resulting in serious violent offenses.lld:pubmed
pubmed-article:10855371pubmed:languagefrelld:pubmed
pubmed-article:10855371pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10855371pubmed:citationSubsetIMlld:pubmed
pubmed-article:10855371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10855371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10855371pubmed:statusMEDLINElld:pubmed
pubmed-article:10855371pubmed:monthAprlld:pubmed
pubmed-article:10855371pubmed:issn0003-410Xlld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:LambertHHlld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:SchmittCClld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:SalvaggioJJlld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:JacobCClld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:RuelMMlld:pubmed
pubmed-article:10855371pubmed:authorpubmed-author:OrizetCClld:pubmed
pubmed-article:10855371pubmed:issnTypePrintlld:pubmed
pubmed-article:10855371pubmed:volume151 Suppl Alld:pubmed
pubmed-article:10855371pubmed:ownerNLMlld:pubmed
pubmed-article:10855371pubmed:authorsCompleteYlld:pubmed
pubmed-article:10855371pubmed:paginationA6-9lld:pubmed
pubmed-article:10855371pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:meshHeadingpubmed-meshheading:10855371...lld:pubmed
pubmed-article:10855371pubmed:year2000lld:pubmed
pubmed-article:10855371pubmed:articleTitle[Abuse of flunitrazepam in opioid addicts].lld:pubmed
pubmed-article:10855371pubmed:affiliationCentre d'Evaluation et d'Information sur les Dépendances (CEIP), CHU, Nancy.lld:pubmed
pubmed-article:10855371pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10855371pubmed:publicationTypeEnglish Abstractlld:pubmed